Human SP-A1 (SFTPA1) variant-specific 3′ UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 4, 2010, Pages

  Silveyra, Patricia ^a   Wang, Guirong ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

microRNA; NCI H441 cells; RRL; Surfactant protein A; Untranslated regions

Indexed keywords

HUMAN SURFACTANT PROTEIN A1; HUMAN SURFACTANT PROTEIN A2; LUCIFERASE; MESSENGER RNA; MICRORNA; POLYADENYLIC ACID; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; SFTPA1 PROTEIN, HUMAN; SFTPA2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOMA CELL; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REPORTER GENE; RETICULOCYTE LYSATE; RNA SPLICING; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; TRANSIENT TRANSFECTION; TRANSLATION REGULATION; ADENOCARCINOMA; ANIMAL; GENE DELETION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; RABBIT; SEQUENCE HOMOLOGY; TUMOR CELL CULTURE;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; GENETIC VARIATION; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; POLY A; PROTEIN BIOSYNTHESIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RABBITS; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 77957336599     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00113.2010     Document Type: Article

References (75)

1. Alexiou P, Maragkakis M, Papadopoulos G, Reczko M, Hatzigeorgiou A. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 25: 3049-3055, 2009.
2. Andreassi C, Riccio A. To localize or not to localize: mRNA fate is in 3′UTR ends. Trends Cell Biol 19: 465-474, 2009.
3. Boggaram V, Mendelson C. Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung. J Biol Chem 263: 19060-19065, 1988. (Pubitemid 19016370)
4. Boggaram V, Smith M, Mendelson C. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol Endocrinol 5: 414-423, 1991.
5. Bruns G, Stroh H, Veldman G, Latt S, Floros J. The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10. Hum Genet 76: 58-62, 1987.
6. Conne B, Stutz A, Vassalli JD. The 3[prime] untranslated region of messenger RNA: A molecular hotspot for pathology? Nat Med 6: 637-641, 2000.
7. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001. (Pubitemid 32304328)
8. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 15: 269-281, 1999.
9. Eberle AB, Stalder L, Mathys H, Orozco RZ, Muhlemann O. Post-transcriptional gene regulation by spatial rearrangement of the 3′ untranslated region. PLoS Biol 6: e92, 2008.
10. Fabian M, Mathonnet G, Sundermeier T, Mathys H, Zipprich J, Svitkin Y, Rivas F, Jinek M, Wohlschlegel J, Doudna J, Chen C, Shyu A, Yates Hannon G Jr, Filipowicz W, Duchaine T, Sonenberg N. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell 35: 868-880, 2009.
11. Fabian M, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379, 2010.
12. Floros J, Fan R. Surfactant protein A and B genetic variants and respiratory distress syndrome: allele interactions. Biol Neonate 80, Suppl 1: 22-25, 2001. (Pubitemid 32453712)
13. Floros J, Fan R, Diangelo S, Guo X, Wert J, Luo J. Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr Int 43: 567-576, 2001.
14. Floros J, Fan R, Matthews A, DiAngelo S, Luo J, Nielsen H, Dunn M, Gewolb I, Koppe J, van Sonderen L, Farri-Kostopoulos L, Tzaki M, Rämet M, Merrill J. Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin Genet 60: 178-187, 2001.
15. Floros J, Lin H, García A, Salazar M, Guo X, DiAngelo S, Montaño M, Luo J, Pardo A, Selman M. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 182: 1473-1478, 2000.
16. Floros J, Thomas N. Genetic variations of surfactant proteins and lung injury, edited by Nakos G and Papathanasiou A. In: Surfactant Pathogenesis and Treatment of Lung Diasease. Kerala, India: Signpost, 2009, p. 25-48.
17. Floros J, Wang G, Mikerov A. Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2 - impact on function. Crit Rev Eukaryot Gene Expr 19: 125-137, 2009.
18. Gallie D, Tanguay R. Poly(A) binds to initiation factors and increases cap-dependent translation in vitro. J Biol Chem 269: 17166-17173, 1994. (Pubitemid 24204039)
19. García-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein A derived from one or both genes. Biochemistry 41: 14041-14053, 2002.
20. Gebauer F, Hentze M. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5: 827-835, 2004.
21. Giri P, Kumar GS. Molecular aspects of small molecules-poly(A) interaction: an approach to RNA based drug design. Curr Med Chem 16: 965-987, 2009.
22. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
23. Griffiths-Jones S, Saini H, van Dongen S, Enright A. miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158, 2008.
24. Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 9: 2751-2760, 2000.
25. Hoover R, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18: 353-362, 1998.
26. Hoover RR, Floros J. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol Lung Cell Mol Physiol 276: L917-L924, 1999.
27. Huang HY, Chien CH, Jen KH, Huang HD. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 34: W429-W434, 2006.
28. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11: 113-127, 2010.
29. Jacobsen A, Wen J, Marks D, Krogh A. Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res 20: 1010-1019, 2010.
30. Kala P, Ten Have T, Nielsen H, Dunn M, Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 43: 169-177, 1998.
31. Karinch A, Deiter G, Ballard P, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta 1398: 192-202, 1998.
32. Karinch A, Floros J. 5′ splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 12: 77-88, 1995.
33. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284, 2007.
34. Krizkova L, Sakthivel R, Olowe S, Rogan P, Floros J. Human SP-A: genotype and single-strand conformation polymorphism analysis. Am J Physiol Lung Cell Mol Physiol 266: L519-L527, 1994.
35. Le Quesne JP, Spriggs KA, Bushell M, Willis AE. Dysregulation of protein synthesis and disease. J Pathol 220: 140-151, 2010.
36. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003.
37. Liang Y. An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Medical Genomics 1: 61, 2008.
38. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166, 2007. (Pubitemid 47019476)
39. Liu Y, Wimmer E, Paul AV. Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta 1789: 495-517, 2009.
40. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, Imataka H, Gehring K, Sonenberg N. Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 28: 6658-6667, 2008.
41. Marttila R, Haataja R, Ramet M, Pokela ML, Tammela O, Hallman M. Surfactant protein A gene locus and respiratory distress syndrome in Finnish premature twin pairs. Annals Med 35: 344-352, 2003. (Pubitemid 37013675)
42. Mathews D, Sabina J, Zuker M, Turner D. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288: 911-940, 1999.
43. Mathonnet G, Fabian M, Svitkin Y, Parsyan A, Huck L, Murata T, Biffo S, Merrick W, Darzynkiewicz E, Pillai R, Filipowicz W, Duchaine T, Sonenberg N. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317: 1764-1767, 2007.
44. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28: 91-98, 2003.
45. Mendell J, Dietz H. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107: 411-414, 2001. (Pubitemid 33152776)
46. Mendelson C. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol 62: 875-915, 2000.
47. Meola N, Gennarino VA, Banfi S. microRNAs and genetic diseases. Pathogenetics 2: 7, 2009.
48. Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004, 2002.
49. Mikerov A, Wang G, Umstead T, Zacharatos M, Thomas N, Phelps D, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75: 1403-1412, 2007.
50. Mikerov A, White M, Hartshorn K, Wang G, Floros J. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol 197: 9-12, 2008.
51. Nana-Sinkam SP, Hunter MG, Nuovo GJ, Schmittgen TD, Gelinas R, Galas D, Marsh CB. Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med 179: 4-10, 2009.
52. Olena AF, Patton JG. Genomic organization of microRNAs. J Cell Physiol 222: 540-545, 2010.
53. Pavlovic J, Papagaroufalis C, Xanthou M, Liu W, Fan R, Thomas N, Apostolidou I, Papathoma E, Megaloyianni E, DiAngelo S, Floros J. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers 22: 277-291, 2006.
54. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Ped Pathol Mol Med 20: 269-292, 2001.
55. Reamon-Buettner S, Cho S, Borlak J. Mutations in the 3′- untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet 8: 38, 2007.
56. Rishi A, Hatzis D, McAlmon K, Floros J. An allelic variant of the 6A gene for human surfactant protein A. Am J Physiol Lung Cell Mol Physiol 262: L566-L573, 1992.
57. Rämet M, Haataja R, Marttila R, Floros J, Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 66: 1569-1579, 2000.
58. Seifart C, Lin H, Seifart U, Plagens A, DiAngelo S, von Wichert P, Floros J. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma. Clin Genet 68: 128-136, 2005.
59. Selman M, Lin H, Montaño M, Jenkins A, Estrada A, Lin Z, Wang G, DiAngelo S, Guo X, Umstead T, Lang C, Pardo A, Phelps D, Floros J. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113: 542-550, 2003.
60. Storz G, Opdyke J, Zhang A. Controlling mRNA stability and translation with small, noncoding RNAs. Curr Opin Microbiol 7: 140-144, 2004. (Pubitemid 38447046)
61. Tagaram H, Wang G, Umstead T, Mikerov A, Thomas N, Graff G, Hess J, Thomassen M, Kavuru M, Phelps D, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 292: L1052-L1063, 2007.
62. Tanguay R, Gallie D. Translational efficiency is regulated by the length of the 3′ untranslated region. Mol Cell Biol 16: 146-156, 1996.
63. Walters R, Bradrick S, Gromeier M. Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression. RNA 16: 239-250, 2010.
64. Wang G, Bates-Kenney S, Tao J, Phelps D, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 43: 4227-4239, 2004.
65. Wang G, Guo X, Diangelo S, Thomas N, Floros J. Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem 11998-12010, 2010.
66. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-L508, 2005. (Pubitemid 41192726)
67. Wang G, Guo X, Floros J. Human SP-A 3′-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 284: L738-L748, 2003.
68. Wang G, Mao W, Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582: 3663-3668, 2008.
69. Wang G, Phelps D, Umstead T, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-α production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278: L946-L954, 2000.
70. Wang G, Umstead T, Phelps D, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002.
71. Wang J, Reid K. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 212: 417-425, 2007.
72. Wickens M, Anderson P, Jackson R. Life and death in the cytoplasm: messages from the 3′ end. Curr Opin Genet Dev 7: 220-232, 1997.
73. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68, 2005.
74. Zubiaga A, Belasco J, Greenberg M. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15: 2219-2230, 1995.
75. Zuker M, Stiegler P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 9: 133-148, 1981.